Rossari Biotech Future Growth
Future criteria checks 3/6
Rossari Biotech is forecast to grow earnings and revenue by 19.2% and 14.5% per annum respectively. EPS is expected to grow by 18.3% per annum. Return on equity is forecast to be 15.4% in 3 years.
Key information
19.2%
Earnings growth rate
18.3%
EPS growth rate
| Chemicals earnings growth | 20.9% |
| Revenue growth rate | 14.5% |
| Future return on equity | 15.4% |
| Analyst coverage | Low |
| Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically
Feb 10
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture
Sep 23Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)
Apr 06Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues
Feb 19Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%
Feb 17I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease
Feb 10Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal
Nov 24With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting
Oct 12Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?
Dec 17Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?
Oct 26
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 24,511 | 1,926 | 1,527 | 2,312 | 2 |
| 3/31/2025 | 21,368 | 1,610 | 512 | 2,423 | 2 |
| 3/31/2024 | 18,306 | 1,307 | -880 | 433 | N/A |
| 12/31/2023 | 17,643 | 1,255 | N/A | N/A | N/A |
| 9/30/2023 | 16,898 | 1,168 | -341 | 631 | N/A |
| 6/30/2023 | 16,318 | 1,078 | N/A | N/A | N/A |
| 3/31/2023 | 16,559 | 1,073 | 1,195 | 1,524 | N/A |
| 12/31/2022 | 16,883 | 1,027 | N/A | N/A | N/A |
| 9/30/2022 | 17,275 | 995 | 729 | 990 | N/A |
| 6/30/2022 | 16,866 | 1,018 | N/A | N/A | N/A |
| 3/31/2022 | 14,830 | 977 | -89 | 294 | N/A |
| 12/31/2021 | 12,623 | 957 | N/A | N/A | N/A |
| 9/30/2021 | 10,438 | 948 | -342 | 129 | N/A |
| 6/30/2021 | 8,310 | 892 | N/A | N/A | N/A |
| 3/31/2021 | 7,093 | 802 | -103 | 478 | N/A |
| 12/31/2020 | 6,507 | 729 | N/A | N/A | N/A |
| 9/30/2020 | 6,031 | 695 | 198 | 1,045 | N/A |
| 6/30/2020 | 5,818 | 666 | N/A | N/A | N/A |
| 3/31/2020 | 6,001 | 653 | -191 | 568 | N/A |
| 3/31/2019 | 5,162 | 457 | 272 | 712 | N/A |
| 3/31/2018 | 2,922 | 254 | 114 | 254 | N/A |
| 3/31/2017 | 2,350 | 143 | N/A | 67 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ROSSARI's forecast earnings growth (19.2% per year) is above the savings rate (6.7%).
Earnings vs Market: ROSSARI's earnings (19.2% per year) are forecast to grow faster than the Indian market (17.6% per year).
High Growth Earnings: ROSSARI's earnings are forecast to grow, but not significantly.
Revenue vs Market: ROSSARI's revenue (14.5% per year) is forecast to grow faster than the Indian market (10% per year).
High Growth Revenue: ROSSARI's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ROSSARI's Return on Equity is forecast to be low in 3 years time (15.4%).